Price Alert

Rallybio Corporation (RLYB)

NASDAQ: RLYB · Real-Time Price · USD

0.59

0.04 (8.06%)

At close: Aug 15, 2025, 12:52 PM

8.06% (1D)

Bid	0.57
Market Cap	24.65M
Revenue (ttm)	761K
Net Income (ttm)	-41.65M
EPS (ttm)	-0.93
PE Ratio (ttm)	-0.63
Forward PE	-0.42
Analyst	Hold

Ask	0.59
Volume	315,230
Avg. Volume (20D)	2,918,345
Open	0.55
Previous Close	0.55
Day's Range	0.54 - 0.59
52-Week Range	0.22 - 1.25
Beta	-1.11

About RLYB

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol RLYB

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for RLYB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Rallybio Corporation is scheduled to release its earnings on Nov 6, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 month ago

+50.24%

Rallybio shares are trading higher after the compa... Unlock content with Pro Subscription

News

1 month ago · benzinga.com

Why Is Microcap Rallybio Stock Trading Higher On Tuesday?

Rallybio Corporation RLYB agreed on Tuesday to sell its interest in REV102, an ENPP1 inhibitor in preclinical development for hypophosphatasia (HPP), to joint venture partner Recursion Pharmaceuticals...

1 month ago · businesswire.com

Rallybio Sells Interest in REV102 Program to Recursion Pharmaceuticals

NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastati...